Genetic variability of the mouse hepatoma cells MH-22a revealed by RAPD-PCR-fingerprinting under different conditions of cultivation

Experimental Oncology

Volumn 27, Issue 2, 2005, Pages 114-119

  Alexandrova, S A ^a   Shvemberger, I N ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

Differentiation; Genetic variability; RAPD PCR; Tumor

Indexed keywords

EOSIN; HEMATOXYLIN; PARAFFIN; PARAFORMALDEHYDE;

ANIMAL CELL; ANTERIOR EYE CHAMBER; ARTICLE; CELL DIFFERENTIATION; CONNECTIVE TISSUE; GENE AMPLIFICATION; GENETIC DISTANCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEPATOMA CELL; MOUSE; NONHUMAN; RANDOM AMPLIFIED POLYMORPHIC DNA;

ANIMALS; ANTERIOR CHAMBER; CLONE CELLS; DNA FINGERPRINTING; EYE NEOPLASMS; GENETIC HETEROGENEITY; GENOME; INJECTIONS, SUBCUTANEOUS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TUMOR CELLS, CULTURED;

EID: 22644432418     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Achille A, Baron A, Zamboni G, Di Pace C, Orlandini S, Scarpa A. Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. Br J Cancer 1998; 78: 1653-60.
2. Alexandrova SA, Shvemberger IN. The analysis of genetic structure of tumor hepatocytes population MH-22a by means of RAPD-PCR. Vopr Onkol 2003; 49: 347-50.
3. Arribas R, Capella G, Tortola S, Masramon L, Grizzle WE, Perucho M, Peinado MA. Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications. J Clin Oncol 1997; 15: 3230-40.
4. Bloch-Shtacher N, Sachs L. Chromosome balance and the control of malignancy. J Cell Physiol 1976; 87: 89-100.
5. De Juan C, Iniesta P, Vega FJ, Peinado MA, Fernandez C, Caldes T, Massa MJ, Lopez JA, Sanchez A, Torres AJ, Balibrea JL, Benito M. Prognostic value of genomic damage in non small cell lung cancer. Br J Cancer 1998; 77: 1971-7.
6. Deeble PD, Murphy DJ, Parsons SJ, Cox ME. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol 2001; 21: 8471-82.
7. Degos L, Wang ZY. All trans-retinoic acid in acute promyelocytic leukemia. Oncogene 2001; 20: 7140-5.
8. Deroo BJ, Archer TK. Glucocorticoid receptor-mediated chromatin remodelling in vivo. Oncogene 2001; 20: 3039-46.
9. Dexter DL. Neoplastic subpopulations in carcinomas. Ann Clin Lab Sci 1981; 11: 98-107.
10. Efron B, Tibshirani RL. An introduction to the bootstrap. New York: Cold Spring Harbor Lab, 1993. 436 p.
11. Harris H, Miller OJ, Klein G, Worst P, Tachibana T. Supression of malignancy by cell fusion. Nature 1969; 223: 363-8.
12. Hogan B, Costantiny F, Lacy E. Manipulating the mouse embryo. New York: Cold Spring Harbor Lab, 1986; 332 p.
13. Keshava C, Keshava N, Zhou G, Whong WZ, Ong TM. Genomic instability in silica- and cadmium chloride-transformed BALB/c-3T3 and tumor cell lines by random amplified polymorphic DNA analysis. Mutat Res 1999; 425: 117-23.
14. Klein G. The role of genes dosage and genetic transpositions in carcinogenesis. Nature 1981; 294: 313-8.
15. Kohno T, Morishita K, Takano H, Shapiro DN, Yokota J. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene 1994; 9: 103-8.
16. Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther 2001; 90: 105-56.
17. Lotem J, Sachs L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene 2002; 21: 3284-94.
18. Lotem J, Sachs L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Seminars Cancer Biol 2002; 12: 339-46.
19. Marks PA, Rifkind RA. Erytroleukemic differentiation. Ann Rev Biochem 1978; 47: 419-48.
20. Mintz B, Cronmiller C. Normal blood cells of anemic genotype in teratocarcinoma-derived mosaic mice. Proc Natl Acad Sci USA 1978; 75: 6247-51.
21. Misra A, Chattopadhyay P, Dinda AK, Sarkar C, Mahapatra AK, Hasnain SE, Sinha S. Extensive intratumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations. J Neurooncol 2000; 48: 1-12.
22. Sachs L. Normal developmental programmes in myeloid leukemia: regulatory proteins in the control of growth and differentiation. Cancer Survey 1982; 1: 321-42.
23. Sachs L. The adventures of a biologist: prenatal diagnosis, leukemia, carcinogenesis and tumor suppression. Adv Cancer Res 1995; 66: 1-40.
24. Shvemberger IN. Normalization of tumor cells. Leningrad: Nauka, 1987; 145 p.
25. Singh KP, Roy D. Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting. Gene 2001; 269: 33-43.
26. Zuna RE, Lehman JM. Heterogeneity of karyotype and growth potential in simian virus 40-transfonned Chinese hamster cell clones. J Natl Cancer Inst 1977; 58: 1463-72.